Skip to main content

Early Childhood Staff Stipend Incentive Program

ATTENTION: The deadline to submit an application for the $1,000 staff stipend was May 31, 2022. No further stipend applications are being accepted at this time. Please stay tuned for future opportunities!

Learn More About the Staff Stipend

On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. This amendment authorizes administration of a single booster dose to children ages five through 11 years old after completion of a primary series with the Pfizer-BioNTech COVID-19 vaccine. On May 19, 2022, the Advisory Committee on Immunization Practices (ACIP) met and voted to approve a recommendation stating, “A single Pfizer-BioNTech COVID-19 vaccine booster dose is recommended for persons ages 5-11 years at least five months after the primary series, under the FDA’s Emergency Use Authorization.”

A technical bulletin, published on May 25, 2022, by the Nevada Department of Health and Human Services, summarizes the recent Pfizer-BioNTech COVID-19 vaccine booster dose recommendation for children. Children eligible to receive the recommended Pfizer-BioNTech COVID-19 vaccine booster dose include:

  • Any individual ages 5 through 11 years old, at least five months after completion of a two-dose Pfizer-BioNTech COVID-19 vaccine primary series; and
  • Any moderately to severely immunocompromised individual ages 5-11 years old, at least three months after completion of a three dose Pfizer-BioNTech COVID-19 vaccine primary series.

Full details are available in the most recent technical bulletin on the web page linked here.

For more updates about medical and health-related facility licensure, visit the
Bureau of Health Care Quality and Compliance blog site.